Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Sermorelin

GHRH (1-29), GRF 1-29 NH2, Sermorelin acetate

Quick Stats
Studies 223
Trials 41
Score 1
1999 pubmed 1 citations

Quantitative growth hormone secretion and final adult height.

Trainer. P J PJ; Palermo. M M; Kirk. J M JM; Fanciulli. G G; Perry. L H LH; Delitala. G G; Besser. G M GM

Key Findings

  • Tall and short men showed no difference in GH response to hypoglycaemia or GHRH stimulation
  • No differences in nocturnal GH pulse number, size, or total secretion between groups
  • Serum IGF‑1 levels were similar regardless of final adult height

Practical Outcomes

  • For biohackers hoping that GH‑boosting peptides like sermorelin will increase adult height, this study suggests it won’t work. In healthy adults, GH output isn’t a key factor for height, so focus on other health goals rather than using GH secretagogues for stature.

Summary

In a study of 40 healthy young men, researchers found that tall and short adults had almost identical growth‑hormone (GH) responses to insulin‑induced hypoglycaemia, GHRH, and during the night, and their IGF‑1 levels were the same, meaning that how much GH your body makes doesn’t decide how tall you end up as an adult.

Abstract

The relationship of quantitative GH secretion to height, growth velocity and puberty is complex and has been the subject of extensive study in children. This study was designed to relate quantitative GH secretion to final height. Twenty tall (> 183 cm, 90th centile for adult height) and 20 short (< 166 cm, 10th centile) postpubertal men who had recently completed linear growth (age range 18-27 years). GH dynamics were studied on four occasions; insulin (0.15 units/kg, iv)-induced hypoglycaemia and GHRH (100 mg, iv) with and without the anticholinesterase, pyridostigmine (120 mg orally). Spontaneous nocturnal GH secretion was assessed by 20 minute sampling from 2100 h until 0600 h. GH was measured by IRMA. Analysis was by comparison of peak GH response and area under the curve (AUC). GH profiles were further analysed using the 'pulsar' programme. The mean height in the tall group was 187.7 cm (range 183-197) compared to 163.5 cm (range 160-166) for the short group. No difference existed between groups in the GH response to hypoglycaemia or GHRH with and without pyridostigmine. Area under the curve, pulse number, length and amplitude for spontaneous nocturnal GH secretion showed no significant difference between the tall and short subjects. Serum IGF-I (mean 230.5 +/- 15. 4 vs. 230.6 +/- 18.9 microg/l) did not differ between the groups. Quantitative GH secretion does not appear to be an important determinant of final height in healthy individuals.

Study Information

Provider

pubmed

Year

1999

Date

1999-11-01T00:00:00.000Z

DOI

10.1046/j.1365-2265.1999.00844.x

Citations

1

References

52